Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mahtab Moayeri

Showing results (41-50 of 105) with videos related to

Pageof 11
Sort By:
Vaccine|June 16, 2022
Receptor-enhanced immunogenicity of anthrax protective antigen is primarily mediated by capillary morphogenesis Protein-2Anita Verma, Mahtab Moayeri, Christopher P Mocca, et al.
Molecular Microbiology|November 23, 2011
Lipoprotein biosynthesis by prolipoprotein diacylglyceryl transferase is required for efficient spore germination and full virulence of Bacillus anthracisShu Okugawa, Mahtab Moayeri, Andrei P Pomerantsev, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 2, 2003
Anthrax lethal factor represses glucocorticoid and progesterone receptor activityJeanette I Webster, Leonardo H Tonelli, Mahtab Moayeri, et al.
Veterinary Immunology and Immunopathology|June 20, 2018
Inflammasomes in livestock and wildlife: Insights into the intersection of pathogens and natural host speciesCatherine E Vrentas, Robert G Schaut, Paola M Boggiatto, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 21, 2009
Capillary morphogenesis protein-2 is the major receptor mediating lethality of anthrax toxin in vivoShihui Liu, Devorah Crown, Sharmina Miller-Randolph, et al.
Antimicrobial Agents and Chemotherapy|December 15, 2010
Auranofin protects against anthrax lethal toxin-induced activation of the Nlrp1b inflammasomeZachary L Newman, Nicole Sirianni, Christina Mawhinney, et al.
Infection and Immunity|June 17, 2009
Novel chimpanzee/human monoclonal antibodies that neutralize anthrax lethal factor, and evidence for possible synergy with anti-protective antigen antibodyZhaochun Chen, Mahtab Moayeri, Devorah Crown, et al.
The Journal of Infectious Diseases|February 16, 2006
Sublethal doses of Bacillus anthracis lethal toxin inhibit inflammation with lipopolysaccharide and Escherichia coli challenge but have opposite effects on survivalXizhong Cui, Yan Li, Xuemei Li, et al.
The Journal of Biological Chemistry|January 8, 2015
A heterodimer of a VHH (variable domains of camelid heavy chain-only) antibody that inhibits anthrax toxin cell binding linked to a VHH antibody that blocks oligomer formation is highly protective in an anthrax spore challenge modelMahtab Moayeri, Clinton E Leysath, Jacqueline M Tremblay, et al.
American Journal of Physiology. Heart and Circulatory Physiology|September 10, 2017
Shock and lethality with anthrax edema toxin in rats are associated with reduced arterial responsiveness to phenylephrine and are reversed with adefovirDante A Suffredini, Yan Li, Wanying Xu, et al.
Pageof 11

Showing results (41-50 of 105) with videos related to

Sort By:
Pageof 11
Vaccine|June 16, 2022
Receptor-enhanced immunogenicity of anthrax protective antigen is primarily mediated by capillary morphogenesis Protein-2Anita Verma, Mahtab Moayeri, Christopher P Mocca, et al.
Molecular Microbiology|November 23, 2011
Lipoprotein biosynthesis by prolipoprotein diacylglyceryl transferase is required for efficient spore germination and full virulence of Bacillus anthracisShu Okugawa, Mahtab Moayeri, Andrei P Pomerantsev, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 2, 2003
Anthrax lethal factor represses glucocorticoid and progesterone receptor activityJeanette I Webster, Leonardo H Tonelli, Mahtab Moayeri, et al.
Veterinary Immunology and Immunopathology|June 20, 2018
Inflammasomes in livestock and wildlife: Insights into the intersection of pathogens and natural host speciesCatherine E Vrentas, Robert G Schaut, Paola M Boggiatto, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 21, 2009
Capillary morphogenesis protein-2 is the major receptor mediating lethality of anthrax toxin in vivoShihui Liu, Devorah Crown, Sharmina Miller-Randolph, et al.
Antimicrobial Agents and Chemotherapy|December 15, 2010
Auranofin protects against anthrax lethal toxin-induced activation of the Nlrp1b inflammasomeZachary L Newman, Nicole Sirianni, Christina Mawhinney, et al.
Infection and Immunity|June 17, 2009
Novel chimpanzee/human monoclonal antibodies that neutralize anthrax lethal factor, and evidence for possible synergy with anti-protective antigen antibodyZhaochun Chen, Mahtab Moayeri, Devorah Crown, et al.
The Journal of Infectious Diseases|February 16, 2006
Sublethal doses of Bacillus anthracis lethal toxin inhibit inflammation with lipopolysaccharide and Escherichia coli challenge but have opposite effects on survivalXizhong Cui, Yan Li, Xuemei Li, et al.
The Journal of Biological Chemistry|January 8, 2015
A heterodimer of a VHH (variable domains of camelid heavy chain-only) antibody that inhibits anthrax toxin cell binding linked to a VHH antibody that blocks oligomer formation is highly protective in an anthrax spore challenge modelMahtab Moayeri, Clinton E Leysath, Jacqueline M Tremblay, et al.
American Journal of Physiology. Heart and Circulatory Physiology|September 10, 2017
Shock and lethality with anthrax edema toxin in rats are associated with reduced arterial responsiveness to phenylephrine and are reversed with adefovirDante A Suffredini, Yan Li, Wanying Xu, et al.
Pageof 11